CATCH, NCT00799136: A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL |
|
|
| Completed | 2 | 6 | Canada | R-EPOCH and cART, Rituxan, Vepesid, Adriamycin, Vincristine, Cytoxan, Prednisone, Truvada, Sustiva | Ontario Clinical Oncology Group (OCOG), Hoffmann-La Roche | Lymphoma, AIDS Related, HIV Infections | 12/12 | 09/13 | | |
